Home
Science and IP
Investors
Our Team
Events
News Releases
Contact
NASDAQ: CMND
FWB: CWY0
News Releases
Below are the latest News Releases for Clearmind Medicine Inc.
16
January
2024
Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement
Read More
10
January
2024
Clearmind Medicine Completed Type A Meeting with the FDA
Read More
14
December
2023
Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing Standards
Read More
28
November
2023
Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program
Read More
27
November
2023
Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures
Read More
21
November
2023
Clearmind Medicine Announces 1-for-30 Reverse Share Split
Read More
17
November
2023
Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance
Read More
15
November
2023
Clearmind Medicine Announces Shareholders Meeting Results
Read More
5
October
2023
Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th
Read More
28
September
2023
Clearmind Medicine to Present at the LD Micro Main Event XVI Investor Conference on October 4th
Read More
18
September
2023
Clearmind Medicine Closes US$2.25 Million Public Offering
Read More
6
September
2023
Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 for AUD
Read More
14
August
2023
Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company
Read More
1
August
2023
Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP
Read More
11
July
2023
Dr. Fatima Cody Stanford Joins Clearmind Medicine's Scientific Advisory Board
Read More
Previous
Next
